Skip to main content

Table 2 Clinical outcomes of patients with pulmonary sclerosing pneumocytoma (N = 61)

From: Pulmonary sclerosing pneumocytoma: clinical features and prognosis

Characteristics

Sublobectomy

(n = 36)

Lobectomy

(n = 25)

P value

Surgery time, min

88.17 (26.49)

125.40 (41.64)

< 0.001***

Intraoperative blood loss, ml

47.92 (29.36)

79.20 (47.52)

0.006**

Chest tube duration, day

2 (1-7)

3 (2-6)

< 0.001***

Postoperative hospital stays, day

4 (2-10)

6 (4-9)

0.003**

Complications, n (%)

2 (5.56)

2 (8)

1.000

Pulmonary infection

0

1

0.410

Prolonged air leak

2

0

0.508

Atelectasis

1

1

1.000

Follow-up time, months

28.5 (7-95)

38.28 (2-92)

0.351

  1. The data was presented as mean (SD) or median (range)
  2. **P < 0.01
  3. ***P < 0.001. Continuous variables were compared using Student’s t test and categorical variables using chi-squared test